Rowe CC, Ackerman U, Browne W, Mulligan R, Pike KL, O'Keefe G, Tochon-Danguy H, Chan G, Berlangieri SU, Jones G, Dickinson-Rowe KL, Kung HP, Zhang W, Kung MP, Skovronsky D, Dyrks T, Holl G, Krause S, Friebe M, Lehman L, Lindemann S, Dinkelborg LM, Masters CL, Villemagne VL. Imaging of amyloid beta in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism. Lancet Neurol. 2008 Feb;7(2):129-35. PubMed.

Recommends

Please login to recommend the paper.

Comments

  1. This paper reports an Aβ ligand (18)F-BAY94-9172 that, due to the half-life of (18)F, is suitable for clinical use. This is an important study and good news for clinicians.

    View all comments by Hilkka Soininen

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

News

  1. Salzburg: Amyloid Imaging Update
  2. Toronto: Sister 18F Ligands Jostle for Primacy
  3. HAI Chicago: Not Just PIB—Other PET Tracers in Clinical Pipeline

Research Timeline Event

  1. First reports of amyloid PET in differential diagnosis; first F-18 tracer